DEMO

Log In | Sign Up



Laboratory Corp of America Holdings

Selected Articles

2025-07-31
GlobeNewswire
Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
2025-07-31
GlobeNewswire
Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer
2025-07-31
GlobeNewswire
Sicca Syndrome (Sjogren) Clinical Trials Market Landscape Report 2025 Featuring Novartis, BMS, ICON, AbbVie, Parexel, Thermo Fisher Scientific, Amgen, Laboratory Corp of America, IQVIA, Syneos Health
2025-02-04
GlobeNewswire
Tourette Syndrome Global Clinical Trials Research Report 2024: Trial Numbers, Latest News, Top Countries, Trial Status, Trial Phase, Sponsor Type and End Point Status
2025-01-21
GlobeNewswire
Growth Trends in the Contract Research Organization (CRO) Industry, 2025-2029 - Global & Country-Level Analysis of Clinical Research, Early Phase Development, Laboratory, and Regulatory Consulting Applications
2025-01-10
GlobeNewswire
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
2024-12-20
GlobeNewswire
Cardiac Marker Tests Pipeline Report Featuring 230+ Companies and Prospective Products by Stages of Development, Segments, Region and Countries, Regulatory Path
2024-12-16
GlobeNewswire
Rare Disease Diagnostics Emerging Technologies and Developments Report - Shift Towards a Multi-omics Approach, Collaboration Between Rare Disease Diagnostics and Pharma Companies
2024-06-25
GlobeNewswire
Global Genetic Toxicology Testing Market Report 2024: Projected to Generate $4.56 Billion in Revenue by 2031, with Cloud and SaaS Platforms Becoming Essential for Market Competitiveness
2024-05-16
Yahoo Entertainment
Insider Sale: EVP, Chief Legal Officer van der Vaart Sandra D Sells Shares of Laboratory Corp ...

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina. US50540R4092 www.labcorp.com